Cours Isodiol International Inc Other OTC
Actions
CA46500L1013
Produits pharmaceutiques
CA 2018 | 19,14 M 17,46 M | CA 2019 | 22,25 M 20,3 M | Capitalisation | 49,96 M 45,59 M |
---|---|---|---|---|---|
Résultat net 2018 | -36 M -32,85 M | Résultat net 2019 | -126 M -115 M | VE / CA 2018 | 12,6 x |
Trésorerie nette 2018 | 15,55 M 14,19 M | Dette nette 2019 | 5,22 M 4,77 M | VE / CA 2019 | 2,48 x |
PER 2018 |
-4,94
x | PER 2019 |
-0,37
x | Employés | - |
Rendement 2018 * |
-
| Rendement 2019 |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/02/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Director/Board Member | - | 21/11/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+42,07% | 6,23 Md | |
-21,20% | 4,19 Md | |
+5,38% | 3,32 Md | |
-16,98% | 2,91 Md | |
-5,82% | 2,42 Md | |
+45,47% | 1,94 Md | |
-12,67% | 1,59 Md | |
-3,91% | 1,58 Md | |
+44,56% | 1,49 Md |